Hospital-Acquired Disease Testing Market - Global Outlook and Forecast 2021-2027

Publisher Name :
Date: 02-Nov-2021
No. of pages: 93

This report contains market size and forecasts of Hospital-Acquired Disease Testing in Global, including the following market information:

Global Hospital-Acquired Disease Testing Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Hospital-Acquired Disease Testing market was valued at 506.5 million in 2020 and is projected to reach US$ 615.1 million by 2027, at a CAGR of 5.0% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hospital-Acquired Disease Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hospital-Acquired Disease Testing Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Hospital-Acquired Disease Testing Market Segment Percentages, By Type, 2020 (%)

- UTI Testing

- SSI Testing

- Pneumococcal Infections Testing

- Bloodstream Infections Testing

- MRSA Testing

China Hospital-Acquired Disease Testing Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Hospital-Acquired Disease Testing Market Segment Percentages, By Application, 2020 (%)

- Small and Medium Sized Hospitals

- Large Sized Hospitals

Global Hospital-Acquired Disease Testing Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Hospital-Acquired Disease Testing Market Segment Percentages, By Region and Country, 2020 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Hospital-Acquired Disease Testing Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Hospital-Acquired Disease Testing Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

- Diatherix Laboratories

- Gen-Probe

- Qiagen

- F. Hoffmann-La Roche

- Cepheid

- Life Technologies Corporation

- Meridian Biosciences

- Cantel Medical Corporation

- Nordion

Hospital-Acquired Disease Testing Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Hospital-Acquired Disease Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hospital-Acquired Disease Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hospital-Acquired Disease Testing Overall Market Size
2.1 Global Hospital-Acquired Disease Testing Market Size: 2021 VS 2027
2.2 Global Hospital-Acquired Disease Testing Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hospital-Acquired Disease Testing Players in Global Market
3.2 Top Global Hospital-Acquired Disease Testing Companies Ranked by Revenue
3.3 Global Hospital-Acquired Disease Testing Revenue by Companies
3.4 Top 3 and Top 5 Hospital-Acquired Disease Testing Companies in Global Market, by Revenue in 2020
3.5 Global Companies Hospital-Acquired Disease Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital-Acquired Disease Testing Players in Global Market
3.6.1 List of Global Tier 1 Hospital-Acquired Disease Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Hospital-Acquired Disease Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hospital-Acquired Disease Testing Market Size Markets, 2021 & 2027
4.1.2 UTI Testing
4.1.3 SSI Testing
4.1.4 Pneumococcal Infections Testing
4.1.5 Bloodstream Infections Testing
4.1.6 MRSA Testing
4.2 By Type - Global Hospital-Acquired Disease Testing Revenue & Forecasts
4.2.1 By Type - Global Hospital-Acquired Disease Testing Revenue, 2016-2021
4.2.2 By Type - Global Hospital-Acquired Disease Testing Revenue, 2022-2027
4.2.3 By Type - Global Hospital-Acquired Disease Testing Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hospital-Acquired Disease Testing Market Size, 2021 & 2027
5.1.2 Small and Medium Sized Hospitals
5.1.3 Large Sized Hospitals
5.2 By Application - Global Hospital-Acquired Disease Testing Revenue & Forecasts
5.2.1 By Application - Global Hospital-Acquired Disease Testing Revenue, 2016-2021
5.2.2 By Application - Global Hospital-Acquired Disease Testing Revenue, 2022-2027
5.2.3 By Application - Global Hospital-Acquired Disease Testing Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Hospital-Acquired Disease Testing Market Size, 2021 & 2027
6.2 By Region - Global Hospital-Acquired Disease Testing Revenue & Forecasts
6.2.1 By Region - Global Hospital-Acquired Disease Testing Revenue, 2016-2021
6.2.2 By Region - Global Hospital-Acquired Disease Testing Revenue, 2022-2027
6.2.3 By Region - Global Hospital-Acquired Disease Testing Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Hospital-Acquired Disease Testing Revenue, 2016-2027
6.3.2 US Hospital-Acquired Disease Testing Market Size, 2016-2027
6.3.3 Canada Hospital-Acquired Disease Testing Market Size, 2016-2027
6.3.4 Mexico Hospital-Acquired Disease Testing Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Hospital-Acquired Disease Testing Revenue, 2016-2027
6.4.2 Germany Hospital-Acquired Disease Testing Market Size, 2016-2027
6.4.3 France Hospital-Acquired Disease Testing Market Size, 2016-2027
6.4.4 U.K. Hospital-Acquired Disease Testing Market Size, 2016-2027
6.4.5 Italy Hospital-Acquired Disease Testing Market Size, 2016-2027
6.4.6 Russia Hospital-Acquired Disease Testing Market Size, 2016-2027
6.4.7 Nordic Countries Hospital-Acquired Disease Testing Market Size, 2016-2027
6.4.8 Benelux Hospital-Acquired Disease Testing Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Hospital-Acquired Disease Testing Revenue, 2016-2027
6.5.2 China Hospital-Acquired Disease Testing Market Size, 2016-2027
6.5.3 Japan Hospital-Acquired Disease Testing Market Size, 2016-2027
6.5.4 South Korea Hospital-Acquired Disease Testing Market Size, 2016-2027
6.5.5 Southeast Asia Hospital-Acquired Disease Testing Market Size, 2016-2027
6.5.6 India Hospital-Acquired Disease Testing Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Hospital-Acquired Disease Testing Revenue, 2016-2027
6.6.2 Brazil Hospital-Acquired Disease Testing Market Size, 2016-2027
6.6.3 Argentina Hospital-Acquired Disease Testing Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hospital-Acquired Disease Testing Revenue, 2016-2027
6.7.2 Turkey Hospital-Acquired Disease Testing Market Size, 2016-2027
6.7.3 Israel Hospital-Acquired Disease Testing Market Size, 2016-2027
6.7.4 Saudi Arabia Hospital-Acquired Disease Testing Market Size, 2016-2027
6.7.5 UAE Hospital-Acquired Disease Testing Market Size, 2016-2027
7 Players Profiles
7.1 Diatherix Laboratories
7.1.1 Diatherix Laboratories Corporate Summary
7.1.2 Diatherix Laboratories Business Overview
7.1.3 Diatherix Laboratories Hospital-Acquired Disease Testing Major Product Offerings
7.1.4 Diatherix Laboratories Hospital-Acquired Disease Testing Revenue in Global (2016-2021)
7.1.5 Diatherix Laboratories Key News
7.2 Gen-Probe
7.2.1 Gen-Probe Corporate Summary
7.2.2 Gen-Probe Business Overview
7.2.3 Gen-Probe Hospital-Acquired Disease Testing Major Product Offerings
7.2.4 Gen-Probe Hospital-Acquired Disease Testing Revenue in Global (2016-2021)
7.2.5 Gen-Probe Key News
7.3 Qiagen
7.3.1 Qiagen Corporate Summary
7.3.2 Qiagen Business Overview
7.3.3 Qiagen Hospital-Acquired Disease Testing Major Product Offerings
7.3.4 Qiagen Hospital-Acquired Disease Testing Revenue in Global (2016-2021)
7.3.5 Qiagen Key News
7.4 F. Hoffmann-La Roche
7.4.1 F. Hoffmann-La Roche Corporate Summary
7.4.2 F. Hoffmann-La Roche Business Overview
7.4.3 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Major Product Offerings
7.4.4 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Revenue in Global (2016-2021)
7.4.5 F. Hoffmann-La Roche Key News
7.5 Cepheid
7.5.1 Cepheid Corporate Summary
7.5.2 Cepheid Business Overview
7.5.3 Cepheid Hospital-Acquired Disease Testing Major Product Offerings
7.5.4 Cepheid Hospital-Acquired Disease Testing Revenue in Global (2016-2021)
7.5.5 Cepheid Key News
7.6 Life Technologies Corporation
7.6.1 Life Technologies Corporation Corporate Summary
7.6.2 Life Technologies Corporation Business Overview
7.6.3 Life Technologies Corporation Hospital-Acquired Disease Testing Major Product Offerings
7.6.4 Life Technologies Corporation Hospital-Acquired Disease Testing Revenue in Global (2016-2021)
7.6.5 Life Technologies Corporation Key News
7.7 Meridian Biosciences
7.7.1 Meridian Biosciences Corporate Summary
7.7.2 Meridian Biosciences Business Overview
7.7.3 Meridian Biosciences Hospital-Acquired Disease Testing Major Product Offerings
7.4.4 Meridian Biosciences Hospital-Acquired Disease Testing Revenue in Global (2016-2021)
7.7.5 Meridian Biosciences Key News
7.8 Cantel Medical Corporation
7.8.1 Cantel Medical Corporation Corporate Summary
7.8.2 Cantel Medical Corporation Business Overview
7.8.3 Cantel Medical Corporation Hospital-Acquired Disease Testing Major Product Offerings
7.8.4 Cantel Medical Corporation Hospital-Acquired Disease Testing Revenue in Global (2016-2021)
7.8.5 Cantel Medical Corporation Key News
7.9 Nordion
7.9.1 Nordion Corporate Summary
7.9.2 Nordion Business Overview
7.9.3 Nordion Hospital-Acquired Disease Testing Major Product Offerings
7.9.4 Nordion Hospital-Acquired Disease Testing Revenue in Global (2016-2021)
7.9.5 Nordion Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Hospital-Acquired Disease Testing Market Opportunities & Trends in Global Market
Table 2. Hospital-Acquired Disease Testing Market Drivers in Global Market
Table 3. Hospital-Acquired Disease Testing Market Restraints in Global Market
Table 4. Key Players of Hospital-Acquired Disease Testing in Global Market
Table 5. Top Hospital-Acquired Disease Testing Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Hospital-Acquired Disease Testing Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Hospital-Acquired Disease Testing Revenue Share by Companies, 2016-2021
Table 8. Global Companies Hospital-Acquired Disease Testing Product Type
Table 9. List of Global Tier 1 Hospital-Acquired Disease Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital-Acquired Disease Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Hospital-Acquired Disease Testing Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Hospital-Acquired Disease Testing Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Hospital-Acquired Disease Testing Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Hospital-Acquired Disease Testing Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Hospital-Acquired Disease Testing Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Hospital-Acquired Disease Testing Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2022-2027
Table 30. Diatherix Laboratories Corporate Summary
Table 31. Diatherix Laboratories Hospital-Acquired Disease Testing Product Offerings
Table 32. Diatherix Laboratories Hospital-Acquired Disease Testing Revenue (US$, Mn), (2016-2021)
Table 33. Gen-Probe Corporate Summary
Table 34. Gen-Probe Hospital-Acquired Disease Testing Product Offerings
Table 35. Gen-Probe Hospital-Acquired Disease Testing Revenue (US$, Mn), (2016-2021)
Table 36. Qiagen Corporate Summary
Table 37. Qiagen Hospital-Acquired Disease Testing Product Offerings
Table 38. Qiagen Hospital-Acquired Disease Testing Revenue (US$, Mn), (2016-2021)
Table 39. F. Hoffmann-La Roche Corporate Summary
Table 40. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product Offerings
Table 41. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Revenue (US$, Mn), (2016-2021)
Table 42. Cepheid Corporate Summary
Table 43. Cepheid Hospital-Acquired Disease Testing Product Offerings
Table 44. Cepheid Hospital-Acquired Disease Testing Revenue (US$, Mn), (2016-2021)
Table 45. Life Technologies Corporation Corporate Summary
Table 46. Life Technologies Corporation Hospital-Acquired Disease Testing Product Offerings
Table 47. Life Technologies Corporation Hospital-Acquired Disease Testing Revenue (US$, Mn), (2016-2021)
Table 48. Meridian Biosciences Corporate Summary
Table 49. Meridian Biosciences Hospital-Acquired Disease Testing Product Offerings
Table 50. Meridian Biosciences Hospital-Acquired Disease Testing Revenue (US$, Mn), (2016-2021)
Table 51. Cantel Medical Corporation Corporate Summary
Table 52. Cantel Medical Corporation Hospital-Acquired Disease Testing Product Offerings
Table 53. Cantel Medical Corporation Hospital-Acquired Disease Testing Revenue (US$, Mn), (2016-2021)
Table 54. Nordion Corporate Summary
Table 55. Nordion Hospital-Acquired Disease Testing Product Offerings
Table 56. Nordion Hospital-Acquired Disease Testing Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Hospital-Acquired Disease Testing Segment by Type
Figure 2. Hospital-Acquired Disease Testing Segment by Application
Figure 3. Global Hospital-Acquired Disease Testing Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Hospital-Acquired Disease Testing Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Hospital-Acquired Disease Testing Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hospital-Acquired Disease Testing Revenue in 2020
Figure 8. By Type - Global Hospital-Acquired Disease Testing Revenue Market Share, 2016-2027
Figure 9. By Application - Global Hospital-Acquired Disease Testing Revenue Market Share, 2016-2027
Figure 10. By Region - Global Hospital-Acquired Disease Testing Revenue Market Share, 2016-2027
Figure 11. By Country - North America Hospital-Acquired Disease Testing Revenue Market Share, 2016-2027
Figure 12. US Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Hospital-Acquired Disease Testing Revenue Market Share, 2016-2027
Figure 16. Germany Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2027
Figure 17. France Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Hospital-Acquired Disease Testing Revenue Market Share, 2016-2027
Figure 24. China Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2027
Figure 28. India Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Hospital-Acquired Disease Testing Revenue Market Share, 2016-2027
Figure 30. Brazil Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Hospital-Acquired Disease Testing Revenue Market Share, 2016-2027
Figure 33. Turkey Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Hospital-Acquired Disease Testing Revenue, (US$, Mn), 2016-2027
Figure 37. Diatherix Laboratories Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Gen-Probe Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Qiagen Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Cepheid Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Life Technologies Corporation Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Meridian Biosciences Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Cantel Medical Corporation Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Nordion Hospital-Acquired Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs